Clinical Trial Update: Ketamine for the Treatment of Refractory Status Epilepticus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ketamine for the treatment of refractory status epilepticus is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Refractory Status Epilepticus | Phase 4 | Status: NOT_YET_RECRUITING